Cargando…
Cannabidiol as a potential treatment for psychosis
Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of disease. The introduction of dopamine D2 receptor antagonists in the 1950s revolutionised the treatment of psychotic disorders and they remain the mains...
Autores principales: | Davies, Cathy, Bhattacharyya, Sagnik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843725/ https://www.ncbi.nlm.nih.gov/pubmed/31741731 http://dx.doi.org/10.1177/2045125319881916 |
Ejemplares similares
-
The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020) -
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine
por: O’Shaughnessy, David M., et al.
Publicado: (2021) -
Psychedelic treatment of functional neurological disorder: a systematic review
por: Butler, Matthew, et al.
Publicado: (2020) -
Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020) -
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
por: Evens, Ricarda, et al.
Publicado: (2023)